Physician
Radiation Oncology
Dr. Daniel R. Gomez, MD
|
|
Give Review
Dr. Daniel R. Gomez works in the field of Radiation Oncology. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care Daniel R. Gomez has written publications. He has 52 publications published with PubMed. The lastest publication is: 'Scientific Advances in Lung Cancer 2015.'
Publications
- Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.
- Prospective Study of Patient-Reported Symptom Burden in Patients with Non-Small Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
- PDL1 Regulation by p53 via miR-34.
- Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.
- Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors.
- Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
- Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung cancer patient outcomes.
- Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
- Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zo...
- Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.
- Failure Patterns Relative to Radiation Treatment Fields for Stage II-IV Thymoma.
- In reply to mihaildis.
- Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy.
- Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive.
- Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study.
- Factors Associated with Local-Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer.
- Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors.
- Cardiac (18)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
- Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.
- Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.
- Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer.
- Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer.
- Biochemical Response to Androgen Deprivation Therapy Before External Beam Radiation Therapy Predicts Long-Term Prostate Cancer Survival Outcomes.
- Aortic dose constraints when reirradiating thoracic tumors.
- Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
- Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer.
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
- Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiati...
- Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: A population-based study.
- ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.
- Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.
- Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly.
- Predictors of High-grade Esophagitis After Definitive Three-dimensional Conformal Therapy, Intensity-modulated Radiation Therapy, or Proton Beam Therapy for Non-small ...
- Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer.
- Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung Cancer.
- HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients after Radio(chemo)therapy for Non-Small Cell Lung Cancer.
- Incorporating Single-nucleotide Polymorphisms Into the Lyman Model to Improve Prediction of Radiation Pneumonitis.
- Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis.
- Spatial correspondence of 4D CT ventilation and SPECT pulmonary perfusion defects in patients with malignant airway stenosis.
- Changes in Pulmonary Function after Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer.
- A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors.
- Correlation of Osteoradionecrosis and Dental Events with Dosimetric Parameters in Intensity-Modulated Radiation Therapy for Head-and-Neck Cancer.
- Adaptive Radiation for Lung Cancer.
- Radiotherapy after surgical resection for head and neck mucosal melanoma.
- Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.
- Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
- Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
- Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.
- High failure rate in spinal ependymomas with long-term follow-up.
- Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.
- Scientific Advances in Lung Cancer 2015.
Schools
Univ Of Ca
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Memorial Sloan-Kettering Cancer Center -
University of California San Francisco School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1790944023 | |
| NPPES Provider LastName | GOMEZ | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 770542002 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 85.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 28.24 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790944023 |
| Last Name Of The Provider | GOMEZ |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Adam S. Garden, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Karen E. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita Mahajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis Delclos, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Quynh-Nhu Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann H. Klopp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle S. Ludwig, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry S. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Bishop, MD |
|
|
Dr. Jonathan D. Grant, MD |
|
|
Dr. Gary V. Walker, MD |